herbalife ltd. - HLF
HLF
Close Chg Chg %
9.71 -0.44 -4.48%
Closed Market
9.27
-0.44 (4.48%)
Volume: 1.57M
Last Updated:
Jul 15, 2025, 3:59 PM EDT
Company Overview: herbalife ltd. - HLF
HLF Key Data
Open $9.68 | Day Range 9.16 - 9.72 |
52 Week Range 5.04 - 12.79 | Market Cap $1.04B |
Shares Outstanding 101.85M | Public Float 98.93M |
Beta 0.89 | Rev. Per Employee N/A |
P/E Ratio 3.53 | EPS $2.77 |
Yield 0.00% | Dividend $0.30 |
EX-DIVIDEND DATE Feb 28, 2014 | SHORT INTEREST N/A |
AVERAGE VOLUME 1.81M |
HLF Performance
1 Week | -8.84% | ||
1 Month | 17.92% | ||
3 Months | 44.10% | ||
1 Year | -16.92% | ||
5 Years | -81.62% |
HLF Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
4
Full Ratings ➔
About herbalife ltd. - HLF
Herbalife Ltd. is a holding company, which engages in the provision of health and wellness products. It operates through the following geographical segments: North America, Latin America, EMEA, Asia Pacific, and China. The company was founded by Mark Reynolds Hughes in February 1980 and is headquartered in Los Angeles, CA.
HLF At a Glance
Herbalife Ltd.
800 West Olympic Boulevard
Los Angeles, California 90015
Phone | N/A | Revenue | 4.99B | |
Industry | Food: Major Diversified | Net Income | 254.30M | |
Sector | Consumer Non-Durables | Employees | 8,600 | |
Fiscal Year-end | 12 / 2025 | |||
View SEC Filings |
HLF Valuation
P/E Current | 3.533 |
P/E Ratio (with extraordinary items) | N/A |
P/E Ratio (without extraordinary items) | 2.673 |
Price to Sales Ratio | 0.136 |
Price to Book Ratio | N/A |
Price to Cash Flow Ratio | 2.382 |
Enterprise Value to EBITDA | 4.773 |
Enterprise Value to Sales | 0.547 |
Total Debt to Enterprise Value | 0.905 |
HLF Efficiency
Revenue/Employee | 580,593.023 |
Income Per Employee | 29,569.767 |
Receivables Turnover | 65.959 |
Total Asset Turnover | 1.803 |
HLF Liquidity
Current Ratio | 0.93 |
Quick Ratio | 0.543 |
Cash Ratio | 0.341 |
HLF Profitability
Gross Margin | 75.841 |
Operating Margin | 9.022 |
Pretax Margin | 3.393 |
Net Margin | 5.093 |
Return on Assets | 9.185 |
Return on Equity | N/A |
Return on Total Capital | 15.244 |
Return on Invested Capital | 18.801 |
HLF Capital Structure
Total Debt to Total Equity | N/A |
Total Debt to Total Capital | 148.022 |
Total Debt to Total Assets | 90.514 |
Long-Term Debt to Equity | N/A |
Long-Term Debt to Total Capital | 128.648 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Herbalife Ltd. - HLF
Collapse All in section
All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
---|---|---|---|---|---|
Sales/Revenue
| 5.80B | 5.20B | 5.06B | 4.99B | |
Sales Growth
| +4.71% | -10.31% | -2.73% | -1.37% | |
Cost of Goods Sold (COGS) incl D&A
| 1.32B | 1.26B | 1.28B | 1.21B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 107.60M | 115.40M | 113.30M | 121.40M | |
Depreciation
| 89.20M | 94.30M | 88.90M | 96.50M | |
Amortization of Intangibles
| 18.40M | 21.10M | 24.40M | 24.90M | |
COGS Growth
| +7.31% | -5.06% | +2.02% | -5.89% | |
Gross Income
| 4.48B | 3.95B | 3.78B | 3.79B | |
Gross Income Growth
| +3.97% | -11.86% | -4.24% | +0.16% | |
Gross Profit Margin
| +77.19% | +75.86% | +74.68% | +75.84% |
2021 | 2022 | 2023 | 2024 | 5-year trend | |
---|---|---|---|---|---|
SG&A Expense
| 3.75B | 3.41B | 3.46B | 3.34B | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 3.75B | 3.41B | 3.46B | 3.34B | |
SGA Growth
| +5.19% | -8.98% | +1.42% | -3.59% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 36.00M | (500.00K) | (1.60M) | 90.50M | |
EBIT after Unusual Expense
| 694.80M | 536.60M | 321.70M | 360.00M | |
Non Operating Income/Expense
| 18.20M | 27.70M | 47.20M | 27.70M | |
Non-Operating Interest Income
| 4.40M | 6.10M | 11.50M | 12.30M | |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 152.20M | 139.50M | 166.20M | 218.30M | |
Interest Expense Growth
| +14.87% | -8.34% | +19.14% | +31.35% | |
Gross Interest Expense
| 152.20M | 139.50M | 166.20M | 218.30M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 560.80M | 424.80M | 203.00M | 169.40M | |
Pretax Income Growth
| +8.60% | -24.25% | -52.21% | -16.55% | |
Pretax Margin
| +9.66% | +8.16% | +4.01% | +3.39% | |
Income Tax
| 113.60M | 103.50M | 60.80M | (84.90M) | |
Income Tax - Current - Domestic
| 25.10M | 33.30M | 21.10M | 54.40M | |
Income Tax - Current - Foreign
| 121.80M | 100.10M | 80.80M | 90.30M | |
Income Tax - Deferred - Domestic
| (16.30M) | (27.90M) | (39.40M) | (63.70M) | |
Income Tax - Deferred - Foreign
| (17.00M) | (2.00M) | (1.70M) | (165.90M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 447.20M | 321.30M | 142.20M | 254.30M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 447.20M | 321.30M | 142.20M | 254.30M | |
Net Income Growth
| +20.02% | -28.15% | -55.74% | +78.83% | |
Net Margin Growth
| +7.71% | +6.17% | +2.81% | +5.09% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 447.20M | 321.30M | 142.20M | 254.30M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 447.20M | 321.30M | 142.20M | 254.30M | |
EPS (Basic)
| 4.2228 | 3.2619 | 1.4364 | 2.5278 | |
EPS (Basic) Growth
| +49.03% | -22.76% | -55.96% | +75.98% | |
Basic Shares Outstanding
| 105.90M | 98.50M | 99.00M | 100.60M | |
EPS (Diluted)
| 4.1293 | 3.2292 | 1.4192 | 2.5029 | |
EPS (Diluted) Growth
| +49.06% | -21.80% | -56.05% | +76.36% | |
Diluted Shares Outstanding
| 108.30M | 99.50M | 100.20M | 101.60M | |
EBITDA
| 838.40M | 651.50M | 433.40M | 571.90M | |
EBITDA Growth
| -0.80% | -22.29% | -33.48% | +31.96% | |
EBITDA Margin
| +14.45% | +12.52% | +8.56% | +11.45% |
Snapshot
Average Recommendation | HOLD | Average Target Price | 8.667 | |
Number of Ratings | 4 | Current Quarters Estimate | 0.466 | |
FY Report Date | 09 / 2025 | Current Year's Estimate | 2.016 | |
Last Quarter’s Earnings | 0.492 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 1.96 | Next Fiscal Year Estimate | 2.512 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 2 | 2 | 3 | 3 |
Mean Estimate | 0.47 | 0.43 | 2.02 | 2.51 |
High Estimates | 0.49 | 0.51 | 2.12 | 2.70 |
Low Estimate | 0.44 | 0.35 | 1.83 | 2.33 |
Coefficient of Variance | 7.87 | 25.82 | 8.00 | 7.47 |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 1 | 1 | 1 |
OVERWEIGHT | 0 | 0 | 0 |
HOLD | 2 | 2 | 2 |
UNDERWEIGHT | 1 | 1 | 1 |
SELL | 0 | 0 | 0 |
MEAN | Hold | Hold | Hold |
SEC Filings for Herbalife Ltd. - HLF
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Herbalife Ltd. - HLF
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Mar 7, 2025 | Juan Miguel Mendoza Director | 135,000 | Open market or private purchase of non-derivative security Non-derivative transaction at $8 per share | 1,080,000.00 |
Feb 26, 2025 | John G. DeSimone Chief Financial Officer | 258,526 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $8.29 per share | 2,143,180.54 |
Feb 26, 2025 | Michael O. Johnson Chairman & CEO; Director | 442,477 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 26, 2025 | Henry C. Wang Chief Legal Officer | 159,517 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $8.29 per share | 1,322,395.93 |
Feb 26, 2025 | Henry C. Wang Chief Legal Officer | 77,433 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 26, 2025 | Jehangir D. Irani SVP, PAO | 64,459 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $8.29 per share | 534,365.11 |
Feb 26, 2025 | Stephan Paulo Gratziani President | 309,734 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Feb 26, 2025 | Troy Hicks Chief Operating Officer | 56,447 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $8.29 per share | 467,945.63 |
Feb 26, 2025 | Troy Hicks Chief Operating Officer | 52,445 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |